BioRestorative Therapies, Inc. has announced a stock repurchase program authorized by its Board of Directors, allowing the company to buy back up to $2 million of its common stock until June 16, 2026.

The total authorized amount is now $500 million. The company has already spent more than half of this. In a regulatory filing that morning, BlackLine disclosed that its board of directors authorized ...

Performance Stock Unit Programs An expert Q&A on the use of performance stock units (PSUs) in public and private companies, traditional PSU design elements, the primary tax and legal issues related to ...

On August 12, 2025, the Board approved a reverse stock split of the Company’s outstanding shares of Common Stock at a ratio of one-for-five (the “Reverse Stock Split”). The Reverse Stock Split is ...

BitMine Immersion Technologies (AMEX:BMNR) has significantly expanded its stock sale capacity, outlining plans to raise up to $24.5 billion to accelerate Ethereum acquisitions. This total includes up ...

Blue Foundry Bancorp has announced its sixth stock repurchase program, authorizing the buyback of up to 1,082,533 shares of its common stock, representing about 5% of its outstanding shares. This ...

Lemonade (NYSE:LMND) said Monday it is in the process of renewing its reinsurance program, having decided to reduce the ceded proportion of its quota share reinsurance from ~55% to ~20%, effective ...